Faculty Opinions recommendation of In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.

2017 ◽  
Author(s):  
Vincent Emery
Keyword(s):  
Phase Ii ◽  
Cytomegalovirus Infection ◽  
Phase Ii Study ◽  
In Utero ◽  
Open Label ◽  
Congenital Cytomegalovirus Infection ◽  
Congenital Cytomegalovirus ◽  
Open Label Phase

scholarly journals In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study

2016 ◽  
Vol 215 (4) ◽  
pp. 462.e1-462.e10 ◽  
Author(s):  
Marianne Leruez-Ville ◽  
Idir Ghout ◽  
Laurence Bussières ◽  
Julien Stirnemann ◽  
Jean-François Magny ◽  
...  
Keyword(s):  
Phase Ii ◽  
Cytomegalovirus Infection ◽  
Phase Ii Study ◽  
In Utero ◽  
Open Label ◽  
Congenital Cytomegalovirus Infection ◽  
Congenital Cytomegalovirus ◽  
Open Label Phase

scholarly journals Ganciclovir Treatment of Symptomatic Congenital Cytomegalovirus Infection: Results of a Phase II Study

1997 ◽  
Vol 175 (5) ◽  
pp. 1080-1086 ◽  
Author(s):  
Richard J. Whitley ◽  
Gretchen Cloud ◽  
William Gruber ◽  
Gregory A. Storch ◽  
Gail J. Demmler ◽  
...  
Keyword(s):  
Phase Ii ◽  
Cytomegalovirus Infection ◽  
Phase Ii Study ◽  
Congenital Cytomegalovirus Infection ◽  
Congenital Cytomegalovirus ◽  
Ganciclovir Treatment

Methotrexate-Paclitaxel-Epirubicin-Carboplatin (M-TEC) Combination Chemotherapy in Patients with Advanced Bladder Cancer: An Open Label Phase II Study

2005 ◽  
Vol 17 (4) ◽  
pp. 444-448 ◽  
Author(s):  
N. Tsavaris ◽  
C. Kosmas ◽  
H. Skopelitis ◽  
A. Dimitrakopoulos ◽  
P. Kopteridis ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Phase Ii ◽  
Combination Chemotherapy ◽  
Phase Ii Study ◽  
Open Label ◽  
Advanced Bladder Cancer ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document